118 related articles for article (PubMed ID: 3555352)
1. Syngeneic graft-vs-host disease.
Ferrara JL
Arch Dermatol; 1987 Jun; 123(6):741-2. PubMed ID: 3555352
[No Abstract] [Full Text] [Related]
2. T-helper lymphocytes and syngeneic graft-versus-host disease.
Bos GM; Majoor GD; van de Gaar MJ; van Breda Vriesman PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3016-7. PubMed ID: 2523170
[No Abstract] [Full Text] [Related]
3. Syngeneic graft-versus-host disease: a report of two cases and literature review.
Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
[TBL] [Abstract][Full Text] [Related]
4. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models.
Bos GM; Majoor GD; Slaaf DW; van de Gaar MJ; Weijmer-van Velzen JS; van Breda Vriesman PJ
Transplant Proc; 1989 Apr; 21(2):3262-3. PubMed ID: 2652812
[No Abstract] [Full Text] [Related]
5. Induction of autologous graft-versus-host disease.
Vogelsang GB; Jones RJ; Hess AD; Geller R; Schucter L; Santos GW
Transplant Proc; 1989 Feb; 21(1 Pt 3):2997-8. PubMed ID: 2650411
[No Abstract] [Full Text] [Related]
6. Age-related factors in the induction of syngeneic GVHD.
Fischer AC; Beschorner WE; Hess AD
Transplant Proc; 1989 Feb; 21(1 Pt 3):3033-5. PubMed ID: 2650419
[No Abstract] [Full Text] [Related]
7. Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
Hess AD; Fischer AC; Beschorner WE
Transplant Proc; 1989 Feb; 21(1 Pt 3):3013-5. PubMed ID: 2523169
[No Abstract] [Full Text] [Related]
8. Acute skin GVHD following syngeneic BMT for CLL.
Deane M; Singer C; Lawler M; McElwaine S; Gomez K; Prentice HG
Bone Marrow Transplant; 1998 Dec; 22(12):1207-9. PubMed ID: 9894725
[TBL] [Abstract][Full Text] [Related]
9. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation.
Hood AF; Vogelsang GB; Black LP; Farmer ER; Santos GW
Arch Dermatol; 1987 Jun; 123(6):745-50. PubMed ID: 3555353
[TBL] [Abstract][Full Text] [Related]
10. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
11. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
Hess AD; Jones RC; Santos GW
Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
[TBL] [Abstract][Full Text] [Related]
12. [Acute GVHD: pathogenesis, symptomatology, stage/severity, and treatment].
Imamura M; Miyazaki T; Kasai M
Nihon Rinsho; 1990 Sep; 48(9):2055-60. PubMed ID: 2232210
[No Abstract] [Full Text] [Related]
13. A two-phase pathogenesis of graft-versus-host disease in mice.
van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
[TBL] [Abstract][Full Text] [Related]
14. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
[TBL] [Abstract][Full Text] [Related]
15. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
17. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
[No Abstract] [Full Text] [Related]
19. Syngeneic graft-versus-host disease: failure of autoregulation in self/non-self discrimination.
Fischer AC; Beschorner WE; Hess AD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):493-500. PubMed ID: 3291287
[No Abstract] [Full Text] [Related]
20. Does thymic epithelial cell insufficiency predispose to chronic graft-versus-host disease after bone marrow transplantation?
Boland J; Atkinson K; Bodinnar T; Biggs J
Transplant Proc; 1985 Apr; 17(2):1709-10. PubMed ID: 3885511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
